QRisk assessment in people living with diabetes 

This session aims to demystify QRisk assessment in people living with diabetes. 

  By the end of this session attendees will be able to:

  • Recognise the rationale for carrying out a QRisk assessment in people with diabetes
  • Implement recommendations in terms of managing diabetes, based on the score
  • Consider how the QRisk score affects the management of hypertension and dyslipidaemia in type 2 diabetes
  • Holistically reduce cardiovascular risk in people living with diabetes


  Date:   11 April 2023

  Time:   19:00 - 20:00

  Cost:  FREE



This Webinar is accredited for 1 hours CPD

This webinar has been sponsored by AstraZeneca.

All our educational events and webinars are unbiased.  In accordance with APBI, pharmaceutical companies sponsoring webinars and events have no input into choosing the speakers or topics.

We need your consent to load the translations

We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.